Burning Rock Biotech Limited (BNR)

EBITDA Growth

-122.02%

Quarterly · Period ending:

BNR logo

BNR EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-122.02%
BNR Quarterly EBITDA YoY % (-120.74% → -122.02%)
High-resolution chart · PNG

BNR ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Burning Rock Biotech Limited EBITDA Growth — Quarterly
Period endingEBITDA Growth
-122.0196%
-29.7454%
151.5299%
44.2013%
93.4232%
88.3615%
66.5747%
82.0792%
11.4923%
35.0749%
79.4414%
25.9073%
51.9361%
29.7888%
-0.3718%
-38.0951%
-40.9839%
-52.8177%
-39.7654%
-38.1625%
-175.0034%
-274.9256%
-55.7452%
-405.0961%
-278.1241%
-846.7808%
-120.7406%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.